Brand-Name Drugs Starting With M
The month or window each one is expected to get its first, lower-cost generic. Each drug opens its own launch page with the patents, approvals and prices behind its month.
This list is aggregated from FDA records, court filings and company announcements. Coded and designed by Dr. Brian Staiger, PharmD, BCPS
Updated October 9, 2026 How we build our data
M
- Macrilen Macimorelin Acetate April 2028
- Mavyret Glecaprevir and Pibrentasvir December 2036
- Mayzent Siponimod 2033 to 2034
- Mekinist Trametinib Dimethyl Sulfoxide 2027 to 2028
- Mektovi Binimetinib 2029 to 2031
- Miebo Perfluorohexyloctane 2034 to 2035
- Mimrylo Rusfertide 2037 to 2038
- Minocin Minocycline Sometime in 2032
- Miplyffa Arimoclomol Citrate 2036 to 2037
- Mirena Levonorgestrel September 2029
- Mitosol Mitomycin May 2029
- Modeyso Dordaviprone August 2039
- Monoferric Ferric Derisomaltose September 2032
- MorphaBond ER Morphine Sulfate No date yet
- Mounjaro Tirzepatide January 2040
- Movantik Naloxegol Oxalate October 2030
- Moxatag Amoxicillin May 2027
- Mulpleta Lusutrombopag September 2030
- Multaq Dronedarone Hydrochloride Jan to Jun 2029
- Multrys Cupric Sulfate, Manganese Sulfate, Selenious Acid, and Zinc Sulfate 2034 to 2035
- Mycapssa Octreotide Acetate 2037 to 2039
- Myfembree Estradiol, Norethindrone Acetate, and Relugolix 2034 to 2035
- Myoview Technetium TC-99M Tetrofosmin Kit 2029 to 2030
- Myqorzo Aficamten 2040 to 2041
- Mytesi Crofelemer October 2031
See every expected first generic month by month on Generic Launches. Not seeing yours? Ask a pharmacist and we will look it up.